Leqembi and Kisunla represent a great step forward in Alzheimer’s treatment. Still, patients need to jump through logistical hurdles to secure a prescription or insurance coverage. And they have to ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...